These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3140134)

  • 1. Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients.
    Raine AE; Carter R; Mann JI; Morris PJ
    Nephrol Dial Transplant; 1988; 3(4):458-63. PubMed ID: 3140134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
    Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patients.
    Azrolan N; Brown CD; Thomas L; Hayek T; Zhao ZH; Roberts KG; Scheiner C; Friedman EA
    Arterioscler Thromb; 1994 Sep; 14(9):1393-8. PubMed ID: 8068598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profile before and after renal transplantation--a longitudinal study.
    Pannu HS; Singh D; Sandhu JS
    Ren Fail; 2003 May; 25(3):411-7. PubMed ID: 12803504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression.
    Raine AE; Carter R; Mann JI; Chapman JR; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1820-1. PubMed ID: 3274428
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cyclosporin on plasma lipoproteins in bone marrow transplantation patients.
    López-Miranda J; Pérez-Jiménez F; Torres A; Espino-Montoro A; Gomez P; Hidalgo-Rojas L; Ordovas JM; Jiménez-Perepérez JA
    Clin Biochem; 1992 Oct; 25(5):379-86. PubMed ID: 1490302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.
    Lancet; 1983 Oct; 2(8357):986-9. PubMed ID: 6138592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipoproteinemia in renal transplantation.
    Gunjotikar RV; Taskar SP; Almeida AF; Acharya VN
    J Postgrad Med; 1994; 40(1):10-2. PubMed ID: 8568706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cyclosporin versus azathioprine treatment in renal transplants in Edinburgh.
    Notghi A; Dick J; Smith G; Anderton JL; Chisholm GD
    Scott Med J; 1989 Jun; 34(3):459-62. PubMed ID: 2665071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N; Ohmori Y; Tsuji T; Oka T
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract]   [Full Text] [Related]  

  • 13. Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients?
    Webb AT; Reaveley DA; O'Donnell M; O'Connor B; Seed M; Brown EA
    Lancet; 1993 Jan; 341(8840):268-70. PubMed ID: 8093917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin and renal graft histology.
    d'Ardenne AJ; Dunnill MS; Thompson JF; McWhinnie D; Wood RF; Morris PJ
    J Clin Pathol; 1986 Feb; 39(2):145-51. PubMed ID: 3512612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid relation ships in dialysis and renal transplant patients.
    Nicholls AJ; Cumming AM; Catto GR; Edward N; Engeset J
    Q J Med; 1981; 50(198):149-60. PubMed ID: 7029600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.
    Zawiasa A; Nowicki M
    Metabolism; 2013 Oct; 62(10):1462-9. PubMed ID: 23866980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
    Hohage H; Arlt M; Brückner D; Dietl KH; Zidek W; Spieker C
    Clin Transplant; 1997 Jun; 11(3):225-30. PubMed ID: 9193847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy and incidence of de novo cancer in renal transplant recipients.
    Kehinde EO; Petermann A; Morgan JD; Butt ZA; Donnelly PK; Veitch PS; Bell PR
    Br J Surg; 1994 Jul; 81(7):985-6. PubMed ID: 7922092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation.
    Hall BM; Tiller DJ; Horvath JS; Duggin GG; Johnson JR; Roy LP; Hurley B; Harris JP; Rogers JR; Stephen MS
    Med J Aust; 1985 Feb; 142(3):179-85. PubMed ID: 3881654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
    Isoniemi H; Tikkanen MJ; Ahonen J; Häyry P
    Transpl Int; 1991 Sep; 4(3):130-5. PubMed ID: 1958276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.